.png){kind=icon}
返回
Model-Based Equivalent Dose Optimization to Develop New Donepezil Patch Formulation
.png){kind=icon}
OA
AI
DOI：10.3390/pharmaceutics14020244.png)
.png){kind=icon}
.png){kind=icon}
分享.png){kind=icon}
收藏
摘要
En 中文
Donepezil patch was developed to replace the original oral formulation. To accurately describe the pharmacokinetics of donepezil and investigate compatible doses between two formulations, a population pharmacokinetic model for oral and transdermal patches was built based on a clinical study. Plasma donepezil levels were analyzed via liquid chromatography/tandem mass spectrometry. Non-compartmental analyses were performed to derive the initial parameters for compartmental analyses. Compartmental analysis (CA) was performed with NLME software NONMEM assisted by Perl-speaks-NONMEM, and R. Model evaluation was proceeded via visual predictive checks (VPC), goodness-of-fit (GOF) plotting, and bootstrap method. The bioequivalence test was based on a 2 x 2 crossover design, and parameters of AUC and C-max were considered. We found that a two-compartment model featuring two transit compartments accurately describes the pharmacokinetics of nine subjects administered in oral, as well as of the patch-dosed subjects. Through evaluation, the model was proven to be sufficiently accurate and suitable for further bioequivalence tests. Based on the bioequivalence test, 114 mg/101.3 cm(2)-146 mg/129.8 cm(2) of donepezil patch per week was equivalent to 10 mg PO donepezil per day. In conclusion, the pharmacokinetic model was successfully developed, and acceptable parameters were estimated. However, the size calculated by an equivalent dose of donepezil patch could be rather large. Further optimization in formulation needs to be performed to find appropriate usability in clinical situations.
Keyword:
donepezil
transdermal patch
equivalent dose optimization
model-based approaches
AI总结
对已上传原文的论文进行重点信息的提取，主要内容包括：简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
IF:
5.5
论文数:
1.5W
被引数:
6.2W
机构
引用论文
Combined proportional and additive residual error models in population pharmacokinetic modellingOAAI
OAAI分享收藏Impact of transdermal drug delivery on treatment adherence in patients with Alzheimer's disease
PREAI
分享收藏A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease.png)
NEUROLOGY
NEUROLOGYIF8.5
PREAI
分享收藏
查看更多内容